Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1141 ARTÍCULOS , VIENDO DEL 1126 AL 1140

Clinical, biological, and imaging features of monogenic Alzheimer's Disease

Pilotto A, Padovani A, Borroni B.

Biomed Res Int. 2013;2013:689591. doi: 10.1155/2013/689591. Epub 2013 Nov 27.

Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration

Duarte AI, Candeias E, Correia SC, Santos RX, Carvalho C, Cardoso S, Plácido A, Santos MS, Oliveira CR, Moreira PI.

Biochim Biophys Acta. 2013 Apr;1832(4):527-41. doi: 10.1016/j.bbadis.2013.01.008. Epub 2013 Jan 11.

A new interpretative paradigm for Conformational Protein Diseases

Agnati LF, Guidolin D, Woods AS, Ciruela F, Carone C, Vallelunga A, Escuela DO, Genedani S, Fuxe K.

Curr Protein Pept Sci. 2013 Mar;14(2):141-60. doi: 10.2174/1389203711314020006.

Transcranial magnetic stimulation of degenerating brain: a comparison of normal aging, Alzheimer's, Parkinson's and Huntington's disease

Ljubisavljevic MR, Ismail FY, Filipovic S.

Curr Alzheimer Res. 2013 Jul;10(6):578-96. doi: 10.2174/15672050113109990133.

Neuroimaging biomarkers of neurodegenerative diseases and dementia

Risacher SL, Saykin AJ.

Semin Neurol. 2013 Sep;33(4):386-416. doi: 10.1055/s-0033-1359312. Epub 2013 Nov 14.

Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases

Bharadwaj PR, Bates KA, Porter T, Teimouri E, Perry G, Steele JW, Gandy S, Groth D, Martins RN, Verdile G.

Transl Psychiatry. 2013 Dec 3;3(12):e332. doi: 10.1038/tp.2013.97.

Animal models of neurodegenerative diseases

Ribeiro FM, Camargos ER, de Souza LC, Teixeira AL.

Braz J Psychiatry. 2013;35 Suppl 2:S82-91. doi: 10.1590/1516-4446-2013-1157.

Presenilin-1 mutations in Alzheimer's disease: an update on genotype-phenotype relationships

Larner AJ.

J Alzheimers Dis. 2013;37(4):653-9. doi: 10.3233/JAD-130746.

Impact of genetic risk assessment on nutrition-related lifestyle behaviours

Vernarelli JA.

Proc Nutr Soc. 2013 Feb;72(1):153-9. doi: 10.1017/S0029665112002741. Epub 2012 Oct 25.

Cervical dystonia in an Alzheimer's disease patient treated with donepezil

Yagi Y, Watanabe Y, Yokote H, Amino T, Kamata T.

Acta Neurol Belg. 2013 Sep;113(3):363-4. doi: 10.1007/s13760-012-0143-9. Epub 2012 Oct 11.

Melatonin and mitochondrial dysfunction in the central nervous system

Cardinali DP, Pagano ES, Scacchi Bernasconi PA, Reynoso R, Scacchi P.

Horm Behav. 2013 Feb;63(2):322-30. doi: 10.1016/j.yhbeh.2012.02.020. Epub 2012 Feb 25.

Deep brain stimulation for the treatment of Alzheimer disease and dementias

Laxton AW, Lozano AM.

World Neurosurg. 2013 Sep-Oct;80(3-4):S28.e1-8. doi: 10.1016/j.wneu.2012.06.028. Epub 2012 Jun 19.

Clinical and neuropathological findings in a patient with familial Alzheimer disease showing a mutation in the PSEN1 gene

Niwa A, Matsuo K, Shindo A, Yata K, Shiraishi T, Tomimoto H.

Neuropathology. 2013 Apr;33(2):199-203. doi: 10.1111/j.1440-1789.2012.01340.x. Epub 2012 Aug 12.

The unravelling of metabolic dysfunctions linked to metal-associated diseases by blue native polyacrylamide gel electrophoresis

Han S, Auger C, Castonguay Z, Appanna VP, Thomas SC, Appanna VD.

Anal Bioanal Chem. 2013 Feb;405(6):1821-31. doi: 10.1007/s00216-012-6413-9. Epub 2012 Sep 22.

Rivastigmine patch for treatment of Alzheimer's disease in clinical practice in Thailand

Kulkantrakorn K, Tanyakitpisal P, Towanabut S, Dejthevaporn C, Rangseekajee P, Pongpakdee S, Laptikultham S, Rodprasert K, Setthawatcharawanich S, Thinkhamrop B.

Psychogeriatrics. 2013 Mar;13(1):1-8. doi: 10.1111/j.1479-8301.2012.00403.x. Epub 2012 Feb 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias